T. Rowe Price Associates’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,036
| Closed | -$356K | – | 2928 |
|
|
2022
Q4 | $356K | Buy |
1,036
+11
| +1% | +$3.78K | ﹤0.01% | 2306 |
|
|
2022
Q3 | $194K | Buy |
1,025
+103
| +11% | +$19.5K | ﹤0.01% | 2553 |
|
|
2022
Q2 | $195K | Buy |
922
+50
| +6% | +$10.6K | ﹤0.01% | 2605 |
|
|
2022
Q1 | $292K | Buy |
872
+56
| +7% | +$18.8K | ﹤0.01% | 2550 |
|
|
2021
Q4 | $266K | Buy |
816
+148
| +22% | +$48.2K | ﹤0.01% | 2642 |
|
|
2021
Q3 | $324K | Buy |
668
+4
| +0.6% | +$1.94K | ﹤0.01% | 2544 |
|
|
2021
Q2 | $309K | Sell |
664
-52
| -7% | -$24.2K | ﹤0.01% | 2582 |
|
|
2021
Q1 | $495K | Buy |
716
+5
| +0.7% | +$3.46K | ﹤0.01% | 2368 |
|
|
2020
Q4 | $525K | Buy |
+711
| New | +$525K | ﹤0.01% | 2217 |
|